Cysteinyl-leukotrienes partly mediate eotaxin-induced bronchial hyperresponsiveness and eosinophilia in IL-5 transgenic mice

American Journal of Respiratory and Critical Care Medicine

Volumn 160, Issue 2, 1999, Pages 571-575

  Hisada, Takeshi ^a   Salmon, Michael ^a   Nasuhara, Yasuyuki ^a   Chung, K Fan ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; EOTAXIN; INTERLEUKIN 5; LEUKOTRIENE C4; PRANLUKAST;

ALLERGENICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRONCHUS HYPERREACTIVITY; CHEMOTAXIS; EOSINOPHIL; EOSINOPHILIA; INFLAMMATORY INFILTRATE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0032807424     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.160.2.9810101     Document Type: Article

References (33)

1. 1. Jose, P. J., D. A. Griffiths-Johnson, P. D. Collins, D. T. Walsh, R. Moqbel, N. F. Totty, O. Truong, J. J. Hsuan, and T. J. Williams. 1994. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J. Exp. Med. 179: 881-887.
2. 2. Rothenberg, M. E., A. D. Luster, C. M. Lilly, J. M. Drazen, and P. Leder. 1995. Constitutive and allergen-induced expression of eotaxin mRNA in the guinea pig lung. J. Exp. Med. 181:1211-1216.
3. 3. Collins, P. D., D. A. Griffiths-Johnson, P. J. Jose, T. J. Williams, and S. Marleau. 1995. Cooperation between interleukin-5 and the chemokine, eotaxin, to induce eosinophil accumulation in vivo. J. Exp. Med. 182:1169-1174.
4. 4. Forssmann, U., M. Uguccioni, P. Loetscher, C. A. Dahinden, H. Langen, M. Thelen, and M. Baggiolini. 1997. Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes. J. Exp. Med. 185: 2171-2176.
5. 5. Rothenberg, M. E., R. Ownbey, P. D. Mehlhop, P. M. Loiselle, M. van de Rijn, J. V. Bonventre, H. C. Oettgen, P. Leder, and A. D. Luster. 1996. Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice. Mol. Med. 2:334-348.
6. 4 integrin-dependent eotaxin induction of bronchial hyperresponsiveness and eosinophil migration in interleukin-5 transgenic mice. Am. J. Respir. Cell Mol. Biol. 20:992-1000.
7. 7. Rothenberg, M. E., W. F. J. Owen, and D. S. Siberstein. 1988. Human eosinophils have prolonged survival, enhanced functional properties and become hypodense when exposed to human interleukin. J. Clin. Invest. 81:1986-1992.
8. 8. Yamaguchi, Y., T. Suda, J. Suda, M. Eguchi, Y. Miura, N. Harada, A. Tominaga, and K. Takatsu. 1988. Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J. Exp. Med. 167:43-56.
9. 9. Clutterbuck, E. J., E. M. Hirst, and C. J. Sanderson. 1989. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6 and GM-CSF. Blood 73:1504-1512.
10. 10. Lopez, A. F., C. J. Sanderson, J. R. Gamble, H. D. Campbell, I. G. Young, and M. A. Vadas. 1988. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J. Exp. Med. 167: 219-224.
11. 11. Hay, D. W., T. J. Torphy, and B. J. Undem. 1995. Cysteinyl leukotrienes in asthma: old mediators up to new tricks. Trends Pharmacol. Sci. 16: 304-309.
12. 12. Krell, R. D., C. J. Dehaas, D. J. Lengel, E. J. Kusner, J. C. Williams, and C. K. Buckner. 1994. Preclinical exploration of the potential antiinflammatory properties of the peptide leukotriene antagonist ICI 204,219 (Accolate). Ann. N.Y. Acad. Sci. 744:289-298.
13. 13. Underwood, D. C., R. R. Osborn, S. J. Newsholme, T. J. Torphy, and D. W. Hay. 1996. Persistent airway eosinophilia after leukotriene (LT) D4 administration in the guinea pig: modulation by the LTD4 receptor antagonist, pranlukast, or an interleukin-5 monoclonal antibody. Am. J. Respir. Crit. Care Med. 154:850-857.
14. 14. Taylor, I. K., K. M. O'Shaughnessy, R. W. Fuller, and C. T. Dollery. 1991. Effect of cvsteinyl-leukotriene receptor antagonist ICI 204-219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects. Lancet 337:690-694.
15. 15. Henderson, W. R., Jr., D. B. Lewis, R. K. Albert, Y. Zhang, W. J. Lamm, G. K. Chiang, F. Jones, P. Eriksen, Y. T. Tien, M. Jonas, and E. Y. Chi. 1996. The importance of leukotrienes in airway inflammation in a mouse model of asthma. J. Exp. Med. 184:1483-1494.
16. 16. Nakamura, Y., M. Hoshino, J. J. Sin, K. Ishii, K. Hosaka, and T. Sakamoto. 1998, Effect of leukotriene receptor antagonist pranlukast on cellular infiltration in the bronchial mucosa of patients with asthma. Thorax 53:835-841.
17. 17. Douglas, I. S., N. M. Munoz, D. Myer, and A. R. Leff. 1998. Exogenous eotaxin augments cytokine-mediated human eosinophil LTC4 secretion (abstract). Am. J. Respir. Crit. Care Med. 157:A700.
18. 18. Dent, L. A., M. Strath, A. L. Mellor, and C. J. Sanderson. 1990. Eosinophilia in transgenic mice expressing interleukin 5. J. Exp. Med. 172: 1425-1431.
19. 19. McLoughlin, M., A. S. Kearney, and N. R. Palepu. 1998. Aqueous stability of SB 210661: kinetics and primary degradation mechanisms of an N-hydroxyurea-containing 5-lipoxygenase inhibitor. J. Pharm. Pharmacol. 50:127-132.
20. 20. Bochnowicz, S., and D. C. Underwood. 1995. Dose-dependent mediation of leukotriene D4-induced airway microvascular leakage and bronchoconstriction in the guinea pig. Prostaglandins Leukot. Essent. Fatty Acids 52:403-411.
21. 21. Fujiwara, H., N. Kurihara, K. Ohta, K. Hirata, H. Matsushita, H. Kanazawa, and T. Takeda. 1993. Effect of a new leukotriene receptor antagonist, ONO-1078, on human bronchial smooth muscle in vitro. Prostaglandins Leukot. Essent. Fatty Acids 48:241-246.
22. 22. Taki, F., R. Suzuki, K. Torii, S. Matsumoto, H. Taniguchi, and K. Takagi. 1994. Reduction of the severity of bronchial hyperresponsiveness by the novel leukotriene antagonist 4-oxo-8-[4-(4-phenyl-butoxy)benzoylamino]-2-(tetrazol-5-yl)-4H-1-benzopyran hemihydrate. Arzneimittelforschung. 44:330-333.
23. 23. van Oosterhout, A. J. M., A. Van der Poel, L. Koenderman, D. Roos, and N. J. Nijkamp. 1994. Interleukin-5 potentiates sulfidopeptide leukotriene production by human eosinophils. Mediat. Inflamm. 3:53-55.
24. 24. Gonzalo, J., C. M. Lloyd, D. Wen, J. P. Albar, T. N. C. Wells, A. Proudfoot, C. Martinez-A, M. Dorf, T. Bjerke, A. J. Coyle, and J. Guttierrez-Ramos. 1998. The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness. J. Exp. Med. 188:157-167.
25. 25. Rothenberg, M. E., J. A. MacLean, E. Pearlman, A. D. Luster, and P. Leder. 1997. Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia. J. Exp. Med. 185:785-790.
26. 26. Arm, J. P., B. W. Spur, and T. H. Lee. 1988. The effects of inhaled leukotriene E4 on the airway responsiveness to histamine in subjects with asthma and normal subjects. J. Allergy Clin. Immunol. 82:654-660.
27. 27. Laitinen, L. A., A. Laitinen, T. Haahtela, V. Vilkka, B. W. Spur, and T. H. Lee. 1993. Leukotriene E4 and granulocytic infiltration into asthmatic airways. Lancet 341:989-990.
28. 28. Burke Gaffney, A., and P. G. Hellewell. 1996. Eotaxin stimulates eosinophil adhesion to human lung microvascular endothelial cells. Biochem. Biophys. Res. Commun. 227:35-40.
29. 29. Tenscher, K., B. Metzner, E. Schopf, J. Norgauer, and W. Czech. 1996. Recombinant human eotaxin induces oxygen radical production, Ca(2+)-mobilizalion, actin reorganization, and CD11b upregulation in human eosinophils via a pertussis toxin-sensitive heterotrimeric guanine nucleotide-binding protein. Blood 88:3195-3199.
30. 30. Elsner, J., R. Hochstetter, D. Kimmig, and A. Kapp. 1996. Human eotaxin represents a potent activator of the respiratory burst of human eosinophils. Eur. J. Immunol. 26:1919-1925.
31. 31. Kobayashi, S., K. Yoshida, A. Mori, H. Sugiyama, M. Suko, H. Okudaira, K. Ito, S. Inokuma, and Y. Matsumura. 1996. [Inhibitory effect of ONO-1078, a novel leukotriene receptor antagonist, on human peripheral blood eosinophils]. Arerugi. 45:1166-1171.
32. 32. Lefort, J., M. A. Nahori, C. Ruffie, B. B. Vargaftig, and M. Pretolani. 1996. In vivo neutralization of eosinophil-derived major basic protein inhibits antigen-induced bronchial hyperreactivity in sensitized guinea pigs. J. Clin. Invest. 97:1117-1121.
33. 33. Gundel, R. H., L. Gordon Letts, and G. J. Gleich. 1991. Human cosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates. J. Clin. Invest. 87:1470-1473.